PRESS RELEASE: The Advaita Collective Announces Working Group for Psychedelic-Assisted Psychotherapy
Raleigh, North Carolina – The Advaita Collective, a consortium of leading behavioral health care organizations, is proud to announce the formation of a working group dedicated to exploring, advancing, and providing psychedelic-assisted psychotherapy. With a firm belief that psychedelic-assisted psychotherapy (PAP) represents the next frontier in mental health treatment, the Advaita Collective aims to harness the potential of these groundbreaking therapies to transform the lives of individuals suffering from mental health disorders.
The Advaita Collective’s psychedelic-assisted psychotherapy working group consists of an interdisciplinary group of team members and external advisors with diverse backgrounds and expertise, all dedicated to pushing the boundaries of mental health care.
Internal Working Group:
- Tripp Johnson, CEO & Founder
- Dr. Matthew Bader, MD, Medical Director
- Marcus Shumate, LCMHC, LCAS, Director of Business Development
- Vidhula Pednekar, MBA, Special Projects Manager
- CJ LoConte, MBA Candidate (Wharton ’24)
Psychedelic-assisted psychotherapy has gained significant attention and momentum in recent years, and the Advaita Collective is at the forefront of this emerging field. The working group will explore the potential benefits of psychedelic substances, such as psilocybin and MDMA, in conjunction with evidence-based therapeutic approaches. The Advaita Collective believes that these therapies have the potential to revolutionize the treatment of mental health disorders by offering new avenues for healing and personal growth.
Founder and CEO of the Advaita Collective, Tripp Johnson, expressed his enthusiasm for the formation of the working group, stating, “Psychedelic-assisted psychotherapy has the potential to transform the landscape of mental health treatment. We are committed to driving research, fostering collaboration, and creating a safe and effective framework for integrating psychedelic assisted therapy into mainstream mental health care. The study of consciousness and how one can improve their subjective experience in the world is at the heart of what we, as behavioral health professionals, do. There is immense promise in the emerging field of psychedelic-assisted therapy, but everyone must proceed with extreme intentionality, caution, and intellectual rigor.”
Since 2019, members of the Advaita Collective have discussed the emerging PAP field and the desire to be on the forefront of innovative therapies. “I doubt psychedelics will be the panacea it is being portrayed to be by some. Nonetheless, it has the most promise of any mental healthcare development in many years,” said Marcus Shumate, LCMHC, LCAS, Director of Business Development for the Advaita Collective.
The Advaita Collective is dedicated to upholding the highest standards of safety, efficacy, and ethical conduct in the exploration of psychedelic-assisted therapy. The working group will collaborate with renowned researchers, clinicians, and organizations to ensure that evidence-based practices and protocols are followed, prioritizing patient safety and well-being throughout the process.
As the field of psychedelic mental health treatment continues to expand, the Advaita Collective recognizes the importance of reputable resources and references. Some notable sources for information on psychedelic-assisted therapy include:
- Multidisciplinary Association for Psychedelic Studies (MAPS) – www.maps.org
- Heffter Research Institute – www.heffter.org
- Usona Institute – www.usonainstitute.org
- Imperial College London – Centre for Psychedelic Research – https://www.imperial.ac.uk/psychedelic-research-centre/
The Advaita Collective is excited to embark on this journey and invites collaboration from professionals and organizations committed to advancing the field of psychedelic-assisted therapy. By leveraging the collective expertise of its members, the Advaita Collective aims to pave the way for a future where mental health treatment is truly transformative and inclusive.
For inquiries, please contact the Advaita Collective via email at communications@aimwellbeing.com
About the Advaita Collective:
Comprised of leading behavioral health care organizations, the Advaita Collective delivers population-specific, whole-person cares. Advaita Integrated Medicine specializes in comprehensive psychiatry, therapy, and behavioral health services, offering expertise in addressing mental health disorders like substance use, addiction, bipolar, anxiety, depression, trauma, PTSD, and ADHD. Green Hill Recovery, a nationally recognized provider, specializes in transformative treatment for young adult males facing substance use and co-occurring mental health disorders. With a values-based, mission-driven approach, the Advaita Collective prioritizes clinical sophistication, care coordination, and integrated care, all aimed at fostering human flourishing through personalized and comprehensive treatment.
To learn more about Advaita Integrated Medicine and the services they provide, please visit their website at www.aimwellbeing.com. To learn more about Green Hill Recovery and the services they provide, please visit their website at www.greenhillrecovery.com.
